PATENT CLAIM ANALYSIS

Application Number: 16060659
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "552000"]

Abstract:
The invention provides a pro-resolving mediator for use in the reduction of reactogenicity induced by administration of a vaccine or immunogenic composition comprising at least an antigen, and vaccines or immunogenic compositions comprising such a pro-resolving mediator.

Claim (Index 18):
The method of  claim 17 , wherein the vaccine or immunogenic composition is delivered intramuscularly or intradermally, and wherein the pro-resolving mediator is delivered transdermally.

Metadata:
- Claim Count in Document: 22.0
- Percentile: 94.0
- Lexical Diversity: 1.25806
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12103136', '12596202', '13020045', '15446508', '15354233']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7320426073630759
- 35 USC 102 Novelty (BERT): 0.5061872603165822
- Combined Prediction Score: 0.7094570726584265
- Mean Citation Score: 223.322114
- Max Citation Score: 239.91882
- Similarity Product: 174.11731532065986

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test